Patent details
93189
Product Name:
Ixekizumab et ses dérivés pharmaceutiquement acceptables (TALTZ)
Basic Information
- Publication number:
- 93189
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
-
EP068464643
- Legal Status:
- Inactive
- Application number:
- 93189
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/15/1085
- Marketing Authorization Type:
-
- Marketing Authorization Date:
- 28/04/2016
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
-
Dates
- Filing date:
- 31/08/2016
- First Marketing Authorization date:
- 28/04/2016
- Grant date:
- 31/10/2016
- Activation date:
- Publication date:
- 31/10/2016
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 28/04/2031
- SPC Extension Expiration:
- 28/04/2031
- Rejection date:
- Withdrawal date:
Owner
- From:
- 31/08/2016
-
-
- Name:
- ELI LILLY AND COMPANY
- Address:
- LILLY CORPORATE CENTER, INDIANAPOLIS, INDIANA 46285, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 31/08/2016
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- LIU Ling
- Address:
- United States (US)
2
- Name:
- NG Kingman
- Address:
- United States (US)
3
- Name:
- LU Jirong
- Address:
- United States (US)
4
- Name:
- TETREAULT Jonathan, Wendell
- Address:
- United States (US)
5
- Name:
- HUANG Lihua
- Address:
- United States (US)
6
- Name:
- ALLAN Barrett
- Address:
- United States (US)
7
- Name:
- CHOW Chi-kin
- Address:
- United States (US)
8
- Name:
- WERNER Andrew, Gordon
- Address:
- United States (US)
Annual Fees
- Annual Fee Due Date:
- 31/12/2026
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-